A phase I/II clinical study for an oral formulation of Belinostat

Trial Profile

A phase I/II clinical study for an oral formulation of Belinostat

Planning
Phase of Trial: Phase I/II

Latest Information Update: 28 Sep 2017

At a glance

  • Drugs Belinostat (Primary)
  • Indications Cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 28 Sep 2017 According to an Onxeo SA media release, the company expects to initiate this study in early 2019.
    • 28 Apr 2017 New trial record
    • 26 Apr 2017 According to an Onxeo SA media release, the company is planning to initiate this trial at the end of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top